ArborGen Holdings (ARB) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
Chairman confirmed quorum, welcomed shareholders, introduced board members, auditors, and advisors, and provided an agenda overview.
Notice of meeting and audited financial statements for the year ended March 31, 2025, were circulated and taken as read.
Annual meeting held on 10 September 2025, chaired by David Knott.
Voting on resolutions was conducted by poll, with online and in-person participation enabled.
Financial performance review
FY2025 was challenging due to economic, market, and weather impacts; revenue decreased 7% year-over-year but remained 13% above FY23.
Net loss after tax was $21.5 million, including a $21.8 million impairment of intangible assets.
Adjusted US GAAP EBITDA was $8.8 million, in line with guidance but below FY2024; disciplined cost management and operational efficiencies continued.
Inventory increased to support business growth; net tangible assets rose to $64.4 million.
Capital expenditure focused 64% on growth initiatives, including US nursery expansions and a new acquisition in Brazil.
Board and executive committee updates
Board strengthened executive teams in both the U.S. and Brazil to support strategy execution.
Board priorities for FY25 included talent development, capital management, operational oversight, and resilience building.
CEO Justin Birch and Chairman David Knott led discussions on strategic direction and performance.
George Adams stood for reelection as director, highlighting his governance and committee roles.
Board size was confirmed as appropriate despite reduced company scale.
Latest events from ArborGen Holdings
- Record revenue, share buyback, and Brazil-led growth amid market and weather challenges.ARB
AGM 202423 Jan 2026 - Record revenue and improved margins driven by Brazil; FY26 EBITDA growth of at least 25% expected.ARB
H1 202625 Nov 2025 - $21.8m impairment and weak sales led to a sharp net loss and equity drop.ARB
H2 202521 Jun 2025 - Revenue down 3% to $12.8m, net loss $2.1m, FY25 EBITDA guidance cut to $8.5–$10m.ARB
H1 202513 Jun 2025 - Record revenue and EBITDA driven by Brazil growth and US resilience, with strong FY25 outlook.ARB
H2 202413 Jun 2025